GlassScriptPhysician profile
Ashley N Rush
NPI 1275713125
$2,216.00
in general payments reported to CMS, 2019-2025
22 companies · $566 in 2025
The $566 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $36.73 · 2021: $59.74 · 2022: $150 · 2023: $689 · 2024: $513 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,767.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $465.42 | 2019-2025 | |
| Astellas Pharma US INC | $285.96 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $159.98 | 2022-2025 | |
| Abbvie INC. | $155.20 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Biogen, INC. | $153.97 | 2025 | Zurzuvae |
| Pfizer INC. | $148.62 | 2019-2025 | |
| Coopersurgical, INC. | $137.70 | 2023-2025 | Endosee, Paragard T 380a, Paragard T 380a |
| Evofem Biosciences, INC. | $113.75 | 2023-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $111.69 | 2019-2025 | Slynd |
| Organon LLC | $95.16 | 2023-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $66.40 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $64.69 | 2021-2024 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Shield Therapeutics INC | $60.83 | 2023-2024 | Accrufer |
| Daiichi Sankyo INC. | $35.33 | 2019 | |
| Amag Pharmaceuticals, INC. | $25.06 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $24.74 | 2019 | |
| Exact Sciences Corporation | $23.30 | 2023 | Cologuard Collection Kit |
| Vertex Pharmaceuticals Incorporated | $20.04 | 2025 | |
| Bausch Health US, LLC | $18.28 | 2019 | |
| Duchesnay USA Incorporated | $18.16 | 2019 | |
| Agile Therapeutics, INC. | $17.63 | 2024 | Twirla |
| Avion Pharmaceuticals | $14.09 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Rush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.